The creation of retatrutide, a novel dual activator targeting both GLP-1 and GIP receptors, represents a complex several-stage synthetic process. Preliminary routes focused on peptide portion coupling, utilizing https://caoimhenvvq197565.aboutyoublog.com/51651204/synthesis-and-study-implementations-of-retatrutide